Lilach Cherry

657 citations
12 papers · 163 indexed · h-index 6
Topics
SARS-CoV-2 and COVID-19 Research (7 papers)Protein purification and stability (4 papers)Herpesvirus Infections and Treatments (2 papers)
Partner nations
IsraelIndiaUnited States

In The Last Decade

Lilach Cherry

12 papers receiving 162 citations

Peers

Lilach Cherry
Comparison fields: 5 of 56
  • Infectious Diseases 65
  • Molecular Biology 55
  • Epidemiology 53
  • Biomedical Engineering 28
  • Immunology 15
Replace Dorothea R. Morris with:
Dorothea R. Morris United States
Andreas Puyskens Germany
Srinivasan Chinnapaiyan United States
Marcel Stern Germany
Maryam Zaheri Switzerland
Marc Bennedbæk Denmark
Jamin Liu United States
Michiko Ujie Japan
Robert J. Ragotte United Kingdom
Julie Sullivan United States
Lilach Cherry relative to Dorothea R. Morris United States Dorothea R. Morris's profile →
Citations per field
00.5×1.5×
Dorothea R. Morris · 1×
Citations per year

Countries citing papers authored by Lilach Cherry

Since Specialization
Citations

This map shows the geographic impact of Lilach Cherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilach Cherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilach Cherry more than expected).

Fields of papers citing papers by Lilach Cherry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilach Cherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilach Cherry. The network helps show where Lilach Cherry may publish in the future.

Co-authorship network of co-authors of Lilach Cherry

This figure shows the co-authorship network connecting the top 25 collaborators of Lilach Cherry. A scholar is included among the top collaborators of Lilach Cherry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilach Cherry. Lilach Cherry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 1
2 7
3 3
4 5
5 2
6 7
7 29
8 50
9 35
10 4
11 15
12 5

About Lilach Cherry

Lilach Cherry is a scholar working on Virology, Infectious Diseases and Physiology, having authored 12 papers that have together received 163 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), Protein purification and stability (4 papers) and Herpesvirus Infections and Treatments (2 papers). The work is most often cited by research in Infectious Diseases (65 citations), Virology (11 citations) and Modeling and Simulation (10 citations). Lilach Cherry has collaborated with scholars based in Israel, India and United States. Frequent co-authors include Nir Paran, Noam Erez, Hadas Tamir, Tomer Israely, Boaz Politi, Sharon Melamed, Edith Lupu, Einat B. Vitner, Yfat Yahalom-Ronen and Hagit Achdout. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026